1. Home
  2. |Insights
  3. |GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

Client Alert | less than 1 min read | 11.18.16

Last month, GAO issued a report on strategic sourcing that addresses how successful the Federal Strategic Sourcing Initiative (FSSI) program has been to date. While the report found that, from FY2011-15, agencies reported spending almost $2 billion through the FSSI and claimed $470 million in savings, the report also found that “agencies’ low use of the FSSIs … diminished the potential savings that could have been achieved” – an underutilization that GAO attributed partially to the Strategic Sourcing Leadership Council agencies directing only “10 percent of their collective spending to the FSSIs[,]” with GAO calling for more aggressive targets to be set.

Insights

Client Alert | 4 min read | 01.07.26

FDA Request for Information Signals New Path for VC Firms and their Portfolio Companies in Federal Contracting

On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026....